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Abstract 
Bridged cyclodextrin dimers and trimers, in which respectively two and three hydrophobic 
cavities lie in close proximity, display much higher binding affinities and molecular selectivities 
than do parent cyclodextrins (CDs). By joining βCD units with links inserted at different 
positions (2-2', 3-2', 6-2' or 6-2'-6'') and interposing spacers of different lengths and shapes, 
multicavity structures can be synthesized that are precisely tailored to fit specific guest 
molecules. This enzyme-mimicking strategy can also be used to generate stable supramolecular 
adducts. A series of CD dimers and trimers was prepared in good yields by carrying out the 
critical synthetic steps under power ultrasound (US) or microwave (MW) irradiation. Starting 
from CD azide and acetylenic derivatives we exploited an efficient MW-promoted Huisgen 1,3-
dipolar cycloaddition in the presence of Cu(I) salts. The resulting bridged CD derivatives gave 
stable adducts with magnetic-resonance-imaging contrast agents (MRI CAs) containing 
gadolinium(III) chelates. These inclusion complexes were found to be 2 to 3 orders of magnitude 
more stable than those formed by βCD and to be endowed with high relaxivity values.  
 
Introduction  
 Cyclodextrins (CDs) find numerous important applications in chemical, biological and 
pharmaceutical technologies.1 Their employs range from analytical separations,2 food manufacturing,3 
enzyme mimics,4 as drug carriers,5 to the delivery of medical diagnostic agents.6 They are among the 
most widely used oligosaccharide hosts for drug complexation, because CD-encapsulated drugs 
usually have a better bioavailability, a longer half-life in the body, unhindered excretion and no extra 
toxicity.7   
Since the pioneer work by Tabushi8 and Harada9 much effort has been devoted to making CD dimers 
(bis-CDs) with a variety of functional tethers.10 Although syntheses and properties of homodimers 
linked through their primary11 or secondary12 faces are well documented, few heterodimers and trimers 
(tris-CDs)13 have been reported to date and not much is known about their binding properties. We 
described improved US- and MW-promoted protocols for β 
CD homodimerization through 6-6' and 2-2' ureido- and thioureido-bridges14 or alkenyl bridges built 
by cross-metathesis reactions in the presence of 2nd-generation Grubbs catalyst.15 Very recently we 
introduced a new, efficient synthetic protocol16 for preparing homo- and heterodimers of α-, β- and 
γCD. It was based on a MW-promoted17 Huisgen 1,3-dipolar cycloaddition18 of CD monoazides and 
CD monoacetylenes resulting in the formation of a 1,2,3-triazole bridge.19  
Owing to problems of selectivity, efficiency and purification, monosubstitution and disubstitution 
of CDs still remain challenging targets. We found that non-conventional techniques (US or MW 
irradiation) could markedly improve several CD functionalizations, to great advantage in terms of 
yields and reaction times.20-22 
Mono-O-propargyl-CDs and monoazido-deoxy-CDs proved to be versatile building blocks for the 
construction of all types of homo- and heterodimers, whether joined ‘head-to-head’ or ‘head-to-tail’. 
Selective mono- and disubstitutions to provide azido derivatives could usually be achieved via 
monotosylation20 as described in our improved protocols that afforded the 3- and 6-monoazido as well 
as the 6,6'-diazido derivative.22 The latter is a suitable building block for preparing CD trimers. 
Mono-O-propargylation on the secondary face was not a straightforward procedure; protective groups 
had to be inserted at C-6 and strict operative conditions adhered to in order to minimize time-
consuming chromatographic purifications (Scheme 1). An alternative strategy for the synthesis of 
dimers employed a spacer molecule bearing two azido groups or two acetylenic moieties that reacted 
with suitably monosubstituted CDs (Scheme 2). 
The key step in the present synthetic protocol is the Huisgen 1,3-dipolar cycloaddition of azides and 
alkynes, that under catalysis with copper(I) salts react regioselectively to give 1,4-disubstituted 1,2,3-
triazoles. It is experimentally straightforward and widely applicable because it shows a high tolerance 
toward many functional groups and proceeds to completion in a large variety of solvents including 
aqueous t-butanol and DMF. The catalyst is usually prepared in situ by reduction of Cu(II) salts (that 
are less expensive and often purer than Cu(I) salts), usually with L-ascorbic acid or sodium L-
ascorbate. When this cycloaddition was carried out under MW irradiation, the reaction time was 
dramatically reduced.  
The other aim of the present work was to investigate our newly-synthesized, water-soluble CD 
multimers as host molecules for adducts containing Gd(III) chelates. The resulting complexes 
should find application as contrast agents (CAs) for MRI diagnostic medical investigations. As 
they have much larger molecular masses than the CAs themselves, they should be endowed wi th 
markedly higher relaxivities owing to their longer rotational correlation times and consequently 
generate better-contrasted images. 
 
Results and Discussion 
Our first goal was to prepare a library of CD dimers and trimers whose CD units would be joined 
‘head-to-head’ or ‘head-to-tail’ through a rigid, chemically stable spacer. The second goal was to 
investigate their ability to host in their supramolecular cavities, and thus firmly bind, CAs bearing 
suitable substituents (e.g. one or more cyclohexyl groups; see Figure 1).  
The key synthetic step was the Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition by which 
monoazido and monoacetylenic CD derivatives could be efficiently linked together through a 1,2,3-
triazole moiety. Our speedy MW-promoted protocol was characterized by short reaction times, good 
yields and easy work-up . 
We adopted two alternative strategies: the first was to directly react two CD derivatives bearing an 
azido and an alkyne group respectively; the second one used a bifunctional spacer - either 1,3-
bis(azidomethyl)benzene or 1,3-bis(propargyloxy)benzene - to join together two appropriate CD 
derivatives by generating two triazole bridges. Scheme 1 resumes the preparation of monopropargyl 
derivatives. 6-O-t-butyldimethylsilyl-CD,24 when reacted under reflux in anhydrous THF with a 
quasi-stoichiometric amount of propargyl bromide (1.1 eq) in the presence of lithium hydride, yielded 
the 2-monoalkynyl derivative and traces of the 3-alkylated product. When a moderate excess of 
bromoalkyne (3 eq)  was used instead, the dialkylated CD was isolated as major product.  
6-Monoazido-CD and 3-monoazido--, - and CD (5 and 10-12 respectively) were prepared as 
recently described by ourselves20,21 and so was 6A,6D-dideoxy-6A,6D-diazido-βCD (18), obtained by 
displacing with sodium azide under MW the primary (C-6) sulfonic ester group of 6A,D-capped-βCD. 
 
 
Scheme 1. Synthesis of monopropargyl CD derivatives. Reagents and conditions: a) TBDMSCl, imidazole, dry pyridine, stirring, rt., 8h 
b) LiH, dry THF/DMSO, propargyl bromide, rfx, 4h.  
Acetylenic and azido derivatives were subjected to cycloaddition in t-butanol/water (1:1) in the 
presence of CuSO4 and L-ascorbic acid under MW
 (90°C, 150 W).17 The same protocol was employed 
to obtain symmetric homodimers (4, 6) using either of the above-mentioned bifunctional cross-linkers, 
viz. 1,3-bis(azidomethyl)benzene (AMB) and 1,3-bis(propargyloxy) benzene (POB). AMB was used in 
our previous work to prepare cross-linked CD derivatives.24 
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Scheme 2. Synthesis of bis-CDs and tris-CDs via Huisgen cycloaddition. Reagents and conditions: a) CuSO4/ascorbic acid, t-BuOH/H2O 
(1:1), MW 85°C, 150 Wmax, 40 min; b) AcCl 2% in CH3OH/CH2Cl2 1:2. 
When we subjected 5 to cycloaddition with a 2-mono-O-propargyl-6-TBDMS-CD, we obtained 
respectively the asymmetric homodimer 8 in the case of CD derivative 2, and two asymmetric 
heterodimers (7, 9) in the case of α- or γCD derivatives (1, 3). As we aimed to compare the respective 
binding properties of such bis-CDs, joined by unlike faces, with those of a bis-CD that was joined by 
like faces, we carried out the cycloaddition on 3-monoazido-α, -or-γCD (11) and mono-O-alkylated-
CD (2). 
 Scheme 3. Synthesis of dimers 7-15. Reagents and conditions: a) CuSO4/ascorbic acid, t-BuOH/H2O (1:1), MW 85°C, 150 Wmax, 40 
min; b) AcCl 2% in CH3OH/CH2Cl2 1:2 
We then attempted the synthesis of a tris-CD from dipropargylated derivatives (16) and 6-monoazido-
-CD (5), but found it more difficult than those of analogous bis-CDs. The operating conditions used 
for the latter, tended here to result in lower yields. Indeed, when carried out in t-butanol/water, the 
reaction stopped short at the dimer intermediate, that precipitated out of the medium; in fact one 
acetylenic group had quite failed to react. When the reaction however was repeated in DMF, the final 
product (17) was isolated in 68% yield. Because di-O-alkylation generated different positional 
isomers, the configuration of our tris-CD is unknown.  
On the other hand when 6A,6D-dideoxy-6A,6D-diazido-βCD (18) and mono-O-propargyl-6-
TBDMS--CD (2) were reacted in DMF, the product was identifiable as 6A,6D-bis((4-(6'-O-hepta-
TBDMS-βCD-2'-yl)-1H-1,2,3-triazol-1-yl)-6A,6D-dideoxy-βCD (19). 
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Scheme 4. Synthesis of trimers 17 and 19. Reagents and conditions: a) CuSO4/ascorbic acid, DMF, MW 85°C, 150 Wmax, 40 min; b) 
AcCl 2% in CH3OH/CH2Cl2 1:2 
Residual copper was removed from crude reaction mixtures by filtration through a silica column and 
crystallisation or, more efficiently, by chelation with diethylenetriamine-pentaacetic acid sodium salt. 
Protecting silyl groups were cleaved off 17 and 19in a few minutes under acidic conditions (2% acetyl 
chloride in methanol). The final products are shown in Scheme 4. 
We studied how our CD dimers and trimers interacted with suitably functionalized CAs for diagnostic 
Magnetic Resonance Imaging (MRI),25 e.g. the complexes shown in Figure 1. Ditopic guest molecules 
can be expected to bind to bis-CDs more strongly than monotopic ones. The efficacy of a Gd(III) 
chelate as CA for MRI is related to its relaxivity (r1p), that can be much enhanced by attaching it to a 
very large molecule such as a bis-CD.15 To minimize its toxicity, the resulting adduct should be non-
covalent rather than covalent in nature, a condition that can be satisfied if the Gd(III) chelate contains 
suitable hydrophobic groups that will behave as guests in the CD cavities. Relative binding parameters 
listed in Table 1 (association constants Ka, relaxivities Rb of the adducts and number of binding sites n) 
, were determined by the Proton Relaxivity Enhancement (PRE) method (see supporting information 
for relevant equations)26, which exploits the increase in relaxation rate of the paramagnetic complex 
that is determined by its binding to a macromolecular substrate. The binding parameters were obtained 
from two different kinds of titration: the first, in which a fixed concentration of the Gd-chelate was 
titrated with variable amounts of CD dimer/trimer (see example in Figure 2), allowed an accurate 
determination of Ka and Rb;  by the second, in which a fixed concentration of the CD dimer/trimer was 
titrated with the Gd-chelate (see example in Figure 3), we determined the number of equivalent, 
independent binding sites. In the latter, as the binding affinity was sufficiently high, the plot of the 
experimental data showed a breaking point corresponding to the substrate saturation. By fitting the 
experimental points with suitable PRE equations we obtained the number of binding sites on the CD 
dimer/trimer. While for the monotopic Gd-1 complex the number of binding sites was found to be 1 
for all the investigated CDs, for bi- and tri-topic Gd-2 and Gd-3 complexes the  number of binding 
sites on the CD dimer/trimer turned out to be fractional (0.5-0.7). Further support to these findings 
emerged when the data were displayed in the form of Scatchard Plots (Figure 4), where the intercept 
on the x axis yields the number of binding sites on the substrate.27 To explain this difference we 
hypothesized that, while in the case of a monotopic Gd-1 complex a simple 1:1 host-guest adduct was 
formed, in the case of ditopic and tritopic complexes three or four dimer molecules might be bridged 
through two or three Gd complexes (n= 2/3 and n=3/4 respectively) (Figure 7). 
 
Figure 1. Structures of Gd complexes used to prepare host-guest adducts. 
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Figure 2. Observed water-proton relaxation rates of 0.53 mM Gd-1 (), 0.37 mM Gd-2 () and 0.48 
mM Gd-3 () solutions as a function of dimer 4 concentration ( 20 MHz, 298K, pH = 7). 
 
Figure 3. Observed water-proton relaxation rates of a  0.75 mM Dimer 4 solution as a function of Gd-
2 concentration ( 20 MHz, 298K, pH = 7). 
 Figure 4. Scatchard plots of data obtained from PRE titrations of: A) 0.75 mM Dimer 4 solution 
with Gd-2 and B) 0.375 mM dimer 4 solution with Gd-1. The graphs clearly point to n=0.7 and to 
n=1 for Gd-2 and Gd-1 respectively. 
 From inspecting Table 1 we can clearly infer a relationship between binding parameters and structural 
features of the interacting compounds. For example, by comparing the interactions between dimer 4 
and Gd-1, Gd-2, and Gd-3 respectively (Fig. 2), we see that an increase in the number of hydrophobic 
cyclohexyl substituents determines an enhancement in the relaxivity of the adducts; on the other hand 
the affinity constant increases only when going from one to two substituents, whereas the addition of a 
third one does not influence it further. A closer investigation of parameters governing the relaxometric 
behaviour of the three CD-dimer adducts has been performed by analysing the relative NMRD 
(Nuclear Magnetic Resonance Dispersion) profiles.28 This approach accurately determines the 
reorientational correlation time (R)29 of each adduct, which is strictly related to its molecular 
dimensions. Figure 5 shows the NMRD profiles of the adducts of dimer 4 with Gd-1, Gd-2 and Gd-3. 
Data were analysed using the Solomon-Bloembergen-Morgan model,30 assuming (on the basis of what 
is observed with free complexes) one water molecule in the inner coordination sphere for each Gd(III) 
complex (q=1) and fixing the exchange lifetime (M) to 200 ns. Both the profile shapes and R values 
determined from the fitting of experimental results (Table 1) may be explained by the formation of 
supramolecular systems of increasing size as we go from Gd-1/dimer 4 to Gd-2/dimer 4 and Gd-
3/dimer 4 inclusion complexes.  
 
Table 1. 
 Gd-1 Gd-2 Gd-3 
Dimer 4 Ka = 4.6×103±130 M-1 
Rb = 12.4±0.20 mM-1s-1 
n=1 
 
NMRD: R = 356±12  ps 
       nss = 0 
-- 
Ka = 3.9×104±207  M-1 
Rb = 24.3±0.30  mM-1s-1 
n=0.66 
 
NMRD: R = 890±17 ps 
       nss = 6±1 
SS = 60 ps 
 
Ka = 4.1×104±250  M-1 
Rb = 27.2±0.25 mM-1s-1 
n=0.7 
 
NMRD: R = 930±23  ps 
       nss = 6±0.8 
SS = 60 ps 
-- 
Dimer 6 Ka = 5.9×103±85  M-1 
Rb = 11.5±0.45  mM-1s-1 
n=1 
-- 
Ka = 5.9×103±115  M-1 
Rb = 25.8±0.18  mM-1s-1 
n=0.66 
 
 
Dimer 7 -- 
-- 
Ka = 1.4×104±97  M-1 
Rb = 21.7±0.31  mM-1s-1 
n=0.5 
-- 
Dimer 8 Ka = 1.1×104±112  M-1 
Rb = 10.8±0.2  mM-1s-1 
n=1 
Ka = 6.1×105±223  M-1 
Rb = 26.1±0.18  mM-1s-1 
n=0.66 
-- 
Dimer 9 Ka = 1.8×103±88  M-1 
Rb = 11.8±0.11  mM-1s-1 
n=1 
-- 
Ka = 3.0×103±103  M-1 
Rb = 27.2±0.26 mM-1s-1 
n=0.5 
 
-- 
Dimer 14 -- 
-- 
Ka = 1.8×104±90  M-1 
Rb = 24.3±0.43  mM-1s-1 
n=0.66 
 
-- 
Trimer 17 Ka = 1.4×104±95  M-1 
Rb = 12.8±0.14  mM-1s-1 
n=1 
 
NMRD: R = 390±88  ps 
       nss = 0 
-- 
Ka = 5.3×104±135  M-1 
Rb = 27±0.18  mM-1s-1 
n=0.7 
 
NMRD: R = 1±0.23  ns 
       nss = 5±1 
SS = 60 ps 
 
Ka = 6.1×103±112  M-1 
Rb = 35.6±0.26  mM-1s-1 
n=1 
 
NMRD: R = 2±0.34  ns 
       nss = 9±1.5 
SS = 60 ps 
Trimer 19 -- 
-- 
-- 
Ka = 1.9×104±113  M-1 
Rb = 24±0.9  mM-1s-1 
n=1 
 
-- 
Ka = Association constant, Rb= Adduct Relaxivity, n = number of binding sites on the dimer) determined by the relaxometric PRE method at 298K and 
neutral pH;  Reorientational correlation times (R), number of second sphere water molecules (nss) and second sphere correlation time (ss). 
 
Figure 5.  
 1/T1 NMRD profiles of Gd-1/Dimer 4 (), Gd-2/Dimer 4  () and Gd-3/Dimer 4 () adducts, as determined at pH=7 and 298K. Solid 
curves through data points were calculated with parameters reported in Table 1. The fitting procedure was been performed by assuming: 
q (number of coordinated water molecules) = 1; r (distance between the GdIII dev’essere pedice ion and the protons of the coordinated 
water molecule)= 3.1Å; a (distance between the GdIII ion and the outer-sphere water proton nuclei = 3.8Å; D (solute–solvent diffusion 
coefficient) = 2.247×10-5 cm2 s-1; M (exchange lifetime of the inner-sphere water molecule) was fixed to the value previously obtained 
for the free complexes (200ns). 
  
Figure 6.  
 
1/T1 NMRD profiles of Gd-1/Trimer 17 (), Gd-2/Trimer 17 () and Gd-3/Trimer 17 () adducts, obtained at pH=7 and 298K. Solid 
curves through the data points were calculated with the parameters reported in Table 1. The fitting procedure was performed by 
assuming: q (number of coordinated water molecules)= 1; r (distance between the GdIII ion and the protons of the coordinated water 
molecule)= 3.1Å; a (distance between the GdIII ion and the outer-sphere water proton nuclei = 3.8Å; D (solute-solvent diffusion 
coefficient) = 2.247×10-5 cm2 s-1; M (exchange lifetime of the inner-sphere water molecule) was fixed to the value previously obtained 
for the free complexes (200ns). 
For adducts of dimer 4 with Gd-2 and Gd-3, quantitative analysis of the NMRD profiles was not 
satisfactory when the simple inner-outer-sphere model was used; thus we assumed that the water 
protons present in the chelate second-coordination sphere also contributed to observed relaxivities. 
This contribution may originate from clusters of water molecules entrapped within the supramolecular 
adducts. Such a behaviour is commonly encountered with adducts formed when a paramagnetic 
complex is non-covalently bound at the surface of a protein28 as well as with the supramolecular “host-
guest” adduct formed by poly-CD and Gd(III) complexes.31 
From the fitting of experimental data we estimated that 5-6 second-sphere water molecules are present 
per Gd(III) ion (see Table 1), at an average distance of 4 Å from each paramagnetic center. This 
second-sphere contribution was analysed on the basis of the Solomon-Bloembergen-Morgan model, 
suitably modified by introducing a generic correlation time (ss) which dealt with modulating the 
dipolar interactions (exchange and/or rotation) of the second-coordination-sphere water molecules. 
The ss values obtained from fitting the experimental NMRD profiles appear to be much shorter than 
R (Table 1), suggesting that they modulate the lifetimes of water molecules lying at the surface of the 
paramagnetic complex. Moreover, the mere contribution from the second coordination sphere does not 
suffice to explain the high relaxivity values of Gd-2/dimer 4 and Gd-3/dimer 4 adducts compared to 
the Gd-1/dimer 4 adduct. This considerable relaxivity enhancement gives strong support to the 
hypotesis that ditopic and tritopic complexes may act as bridges linking two or three dimer molecules, 
resulting in larger supramolecular adducts endowed with longer reorientational correlation times and 
consequently higher relaxivities (Fig. 7). 
 
Figure 7. Hypothetic interaction mode in Gd-1/, Gd-2/ and Gd-3/dimer adducts. 
  
Some further considerations may be appropriate regarding the association constants (Table 1) 
determined for the interactions of the Gd-2 complex with the other dimers here reported.  
By comparing the binding properties of Gd-2 towards dimers 4 and 6, in which the two CD units are 
linked by the same spacer which is however fastened to different positions on the CD surfaces, we find 
that the association constant is one order of magnitude larger when the two CD units are joined by 
their larger faces.  
In the case of asymmetric heterodimers 7, 8 and 9 interacting with Gd-2, a markedly larger association 
constant was found when both CDs were . The binding affinity determined for this particular system 
was one order of magnitude larger than those found for all other systems. 
Moreover, when we compare the binding properties of Gd-2 toward a bis-CD joined by unlike faces 
(dimer 8) with those shown toward a bis-CD joined by like faces (dimer 14), we see that the affinity is 
one order of magnitude lower in the latter case. These differences in the affinity constant are certainly 
due to the different dimensions relative orientations and of the two CD cages. For this type of guest 
molecules, in which the interacting unit is cyclohexane, the best cavity size is offered by CD and the 
best orientation is presented by the dimer in which the CD units are joined by unlike faces. 
Finally we investigated the binding properties of the three complexes reported in Figure 5 with CD 
trimers 17 and 19. The strenght of interaction seems to remain in the same order of magnitude as found 
in the case of dimeric systems, but with Gd-3/trimer complexes relaxivity values turned out to be even 
higher. The NMRD profiles of Gd-1, Gd-2 and Gd-3 adducts with trimer 17 are reported in Figure 6. 
Their higher relaxivity values (compared to  those of dimeric adducts) are supported by longer R 
values resulting from the larger dimensions of these supramolecular systems.  
 
Conclusions 
A new approach to the preparation of CD dimers and trimers has been introduced. It employs CDs 
that are regioselectively monosubstituted with acetylenic and azido groups, or, alternatively, the 
same in association with disubstituted aromatic spacers bearing either reactive function. These 
versatile derivatives were subjected to a MW-promoted Huisgen cycloaddition that led to the 
formation of bis- and tris-CDs. Access to a library of CD dimers and trimers featuring different 
linkage positions on CD surfaces and cavities of different dimensions should enable us to better 
tune the interaction between the guest molecule (drug, diagnostic marker, etc.) and the CD carrier . 
Our study with medical diagnostic markers (MRI contrast agents) as guest molecules bore out this 
concept. Moreover stability constants and relaxivities found for the adducts of Gd(III) chelates 
with our CD multimers, especially trimers, recommend these supramolecular systems as promising 
candidates for MRI applications. 
Experimental 
General 
 
Materials and methods: Reactions were monitored by TLC on Merck 60 F254 (0.25 mm) plates, which 
were visualized by UV inspection and/or by heating after a spray with 5% H2SO4 in ethanol. Merck 
silica gel was used for column chromatography (CC). IR spectra were recorded with a Shimadzu FT-
IR 8001 spectrophotometer. Unless stated otherwise, NMR spectra were recorded with a Bruker 300 
Advance (300 MHz and 75 MHz for 1H and 13C, respectively) at 25°C; chemical shifts are calibrated 
to the residual proton and carbon resonances of the solvent: CDCl3 (H = 7.26, C = 77.0). Chemical 
shifts () are given in ppm, coupling constants (J) in Hz. MALDI-TOF MS spectra were recorded on a 
Bruker Reflex III spectrometer, ESI-mass spectra on a Waters Micromass ZQ equipped with ESI 
source. MW-promoted reactions were carried out in a professional oven from Microsynth - Milestone 
(Italy). Commercially available reagents and solvents were used without further purification unless 
otherwise noted. Native CDs were kindly provided by Wacker Chemie. Gd1-3 (Figure 1) were kindly 
provided by Bracco Imaging Spa (Italy). 
 
 
Synthesis  
 
2I-O-propargyl-6I-VIIO(t-butyldimethylsilyl)-βCD (2), 61-azido-61-deoxy-CD (5) and 3I-deoxy-3I-
altro-azido-α, -β and -γCD (10, 11, 12) and biphenyl-4,4′-disulfonyl-A,D-capped βCD were prepared 
following published procedures.20,22,32 O-propargyl derivatives of α- and γCD (1, 3) had not so far been 
described in the literature. 
2I-propargyl-6I,VII-O-TBDMS-αCD (1) 
6I-VII-O-TBDMS-CD (3 g, 1.8 mmol) and LiH (43 mg, 5.4 mmol) were dissolved in anhydrous THF 
(25 mL). The solution was heated 2 h under reflux. After it had cooled down to room temperature, 
80% propargyl bromide in toluene (292 μL, 2 mmol) dissolved in 2 mL of THF was added dropwise 
and the mixture was stirred overnight at room temperature. The reacted mixture was diluted with 
EtOAc, washed with 1M H2SO4 and brine, and finally dried (Na2SO4). The crude residue, purified by 
CC (CHCl3–acetone) yielded 1.35 g of derivative 1 (0.8 mmol, yield 44%). 
1 is a white powder; Rf = 0.43 (CHCl3/CH3OH 4:1); max(KBr)/cm-1 3420, 2930, 1473, 1361, 1084, 
1041 and 835; H(300 MHz; CDCl3) 4.5 (br s, 6H, 1-H), 4.04 (br d, J 9.4, 1H, 1'-H), 3.98 (br d, J 9.4, 
1H, 1'-H), 4.0-3.49 (m, 36H), 2.43 (br. s, 1H, 3'-H), 1.08 (s, 54H, t-but) and 0.05 (s, 36H, Si-CH3); m/z 
(ESI-MS) calcd. for [M+H]+ 1697.4, found 1697.3. 
 
2I-propargyl-6I,VII-O-TBDMS-γCD (3) 
6I-VII-O-TBDMS-γCD (3 g, 1.35 mmol) and LiH (30 mg, 3.75 mmol) were dissolved in anhydrous 
THF (25 mL) and the solution was heated 2 h under reflux. After it had cooled down to room 
temperature, 80% propargyl bromide in toluene (221 μL, 1.48 mmol), diluted in 2 mL of THF, was 
added dropwise and the mixture was stirred overnight at room temperature. The reacted mixture was 
diluted with EtOAc, washed with 1M H2SO4 and brine, and finally dried (Na2SO4). The crude residue, 
purified by CC (CHCl3-Acetone) yielded 1.57 g of derivative 3 (0.702 mmol, yield 52%). 
3 is a white powder; Rf = 0.25 (CHCl3/CH3OH 4:1); max(KBr)/cm-1 3420, 2930, 1471, 1362, 1086, 
1035 and 835; H(300 MHz; CDCl3) 5.1-4.9 (m, 8H, 1-H), 4.78 (br d, J 8.1, 2H, 1'-H), 4.11-3.40 (m, 
48H), 2.1 (br. s, 1H, 3'-H), 0.9 (s, 72H, t-but) and 0.05 (s, 48H, Si-CH3); m/z (MALDI-TOF MS) calcd. 
for [M+Na]+ 2270.120, found 2270.148. 
Di-O-propargyl-6I,VII-O-TBDMS-βCD (16). 
6I-VII-O-TBDMS-CD (3 g, 1.55 mmol) and LiH (37 mg, 4.6 mmol) were dissolved in anhydrous THF 
(12 mL). The solution was heated 2 h under reflux. After it had cooled down to room temperature, 
80% propargyl bromide in toluene (690 μL, 4.65 mmol), diluted in 2 mL of THF, was added dropwise 
and the mixture was stirred overnight at room temperature. The reacted mixture was diluted with 
EtOAc, washed with 1M H2SO4 and brine, and finally dried (Na2SO4). The crude residue, purified by 
CC (CHCl3-CH3OH 19:1, 9:1, 4:1) yielded 1.24 g of di-O-alkylated-CD (0.62 mmol, yield 40%). 
16 is a white powder; Rf = 0.26 (CHCl3/CH3OH 4:1); max(KBr)/cm-1 3420, 3325, 1473, 1254, 1086, 
1040 and 835; H(300 MHz; CDCl3) 4.9 (br s, 7H, 1-H), 4.5 (br q, J 16.8, 4H, 1'-H), 4.1-3.9 (m, 14H), 
3.8-3.5 (m, 28H), 2.4 (br. t, J 2.3, 2H, 3'-H), 0.88 (s, 63H, t-but) and 0.05 (s, 42H, Si-CH3); m/z 
(MALDI-TOF MS) calcd. for [M+Na]+ 2031.996, found 2032.322. 
 
6A,6D-diazido-6A,6D-dideoxy-βCD (18). 
The reaction was carried out under magnetic stirring in a professional MW oven, temperature 
being monitored with a fibre-optic thermometer. 500 mg (0.35 mmol) of biphenyl-4,4'-disulfonyl-
A,D-capped βCD and 66 mg (1.05 mmol) of sodium azide were dissolved in 5 ml of DMF. The 
mixture was irradiated with MW (120W) at 85°C for 40 min. The solvent was then partially 
evaporated and the product precipitated with 7 ml of water/acetone 1:10. 403 mg of pure 6 A,6D-
diazido-6A,6D-dideoxy-βCD were recovered (yield 96 %). Analytical data were in accordance with 
reported values.33 
 
General procedure for Cu-catalyzed Huisgen 1,3-dipolar cycloadditions  
In a 10 mL two-necked round-bottomed flask (equipped with an optical-fiber thermometer for 
reactions under MW) 1 mmol of the alkyl azide and 1 mmol of the acetylenic derivative were 
suspended in 5 mL of a t-BuOH/H2O 1:1  mixture. 0.6 mmol of CuSO4·5H2O and 1.2 mmol of L-
ascorbic acid were added. The mixture was irradiated with MW at constant temperature (90°C, 
max power 150 W) and the reaction monitored by TLC until complete conversion of the starting 
material was observed. Water (30 mL) was then added; the precipitate was filtered off and washed 
with a cold 40 mM solution of diethylenetriamine-pentaacetic acid sodium salt (20 mL) to remove 
copper, and finally with water. 
 
General procedure for deprotection.  
The crude product (1 mmol) was dissolved in CH2Cl2 (20 mL), a 2% solution of AcCl in MeOH 
(10 mL) was added and the mixture was stirred overnight at room temperature. Ether (50 mL) was 
then added; the precipitate was filtered, washed with ether (40 mL) and dried under vacuum.  
 
1,3-bis((4-(βCD-2'-yl-methyl)-1H-1,2,3-triazol-1-yl)methyl)benzene (4).  
The reaction was carried out with 2I-O-propargyl-6I-VII-O-TBDMS-CD (2) (500 mg, 0.25 mmol) and 
1,3-bis(azidomethyl) benzene (AMB, 23 mg, 0.12 mmol). The reacted mixture was diluted with 
EtOAc, washed with H2O and brine and finally dried (Na2SO4). The crude product, when purified by 
CC (CHCl3/CH3OH = 19:1, 9:1, 4:1), yielded 370 mg of 6
I-VIITBDMS β-β dimer (0.09 mmol, yield 
75%) as a white powder. Rf = 0.43 (CHCl3/CH3OH 4:1) and 0.56 (EtOAc/MeOH/H2O =40:7:5); 
max(KBr)/cm-1 3422, 1473, 1389, 1254, 1086, 1040 and 835; δH(300 MHz; CDCl3) 7.9 (s, 2H, 5-H 
triazole), 7.4 (m, 1H, 5-H), 7.35-7.3 (m, 3H, 2-H, 4-H, 6-H), 5.53 (s, 4H, -N-CH2-Ph), 4.9 (m, 18H, 1'-
H, overlapped 4 H, triazole-CH2-O), 4.09-3.9 (m, 28H), 3.7-3.4 (m, 56H), 0.88 (s, 126H, t-but), 0.05 
(s, 84H, Si-CH3); δC(75 MHz; CDCl3) 145.1 (C-4 triazole), 135.8 (C-1,3), 130.1 (C-5), 128.8, 128.2, 
128.0 (C-2,C-4,C-6), 124.2 (C-5 triazole), 102.7 (C-1'), 82.1 (C-4'), 73.8, 73.4, 73.2 (C-2',C-3',C-5'), 
65.3 (C triazole -CH2-O), 62.1 (C-6'), 54.7 (C N-CH2-Ph), 26.4 (C-Me3), 18.7 (C-Me3), -4.0, -4.2 (Si-
Me2); m/z (MALDI-TOF MS) calcd. for [M+Na]
+ 4153.053, found 4152.388. 370 mg of 6I-VIITBDMS 
β-β dimer (0.09 mmol) were deprotected to obtain 180 mg of β-β dimer 4 (180 mg, 0.07 mmol, yield 
80%). 
4 is a white powder. Rf = 0.51 (CH3CN/H2O 2:1); max(KBr)/cm-1 3435, 1490, 1399, 1257, 1090, 1050 
and 852; H(300 MHz; D2O) 7.9 (s, 2H, 5-H triazole), 7.3 (t, J 7.9, 1H, 5-H), 7.2 (d, 2H,  J 7.9, 4,6-H), 
7.1 (s, 1H, 2-H), 5.53 (s, 4H, -N-CH2-Ph), 4.9 (m, 14H, 1'-H), 4,7 (m, 4H, triazole-CH2-O), 3.9-3.7 (m, 
56H), 3.6-3.4 (m, 24H), 3.4 (dd, J 9.9 and 3.6, 2H, 2'-H), 3.2 (t, J 9.9, 2H, 4'-H);C(75 MHz; D2O) 
144.2 (C-4 triazole); 136.1 (C-1,C-3), 130.4, 128.7, 128.6, 127.9 (C-2,C-4,C-5,C-6), 126.0 (C-5 
triazole), 102.2 (C-1'), 81.8 (C-4'), 73.8, 73.4, 73.2 (C-2',C-3',C-5'), 65.3 (C triazole-CH2-O), 60.6 (C-
6'), 54.1 (N-CH2-Ph); m/z (MALDI-TOF MS) calcd. for [M+Na]
+ 2555.842, found 2556.074. 
 
1,3-bis((1-(6'-deoxy-βCD-6'-yl)-1H-1,2,3-triazol-4-yl)methoxy)benzene (6).  
The reaction was carried out with 61-azido-61-deoxy-CD (5) (400 mg, 0.34 mmol) and 1,3-
bis(propargyloxy)benzene (POB) (23 mg, 0.12 mmol). Acetone (30 ml) was added to the reacted 
mixture and the precipitate was filtered off. The solid was recrystallised from water/acetone 1:2 and 
215 mg of pure dimer 6 were recovered (0.084 mmol, yield 70%).  
Analytical data were in accordance with reported values.34 
6 is a white powder. Rf = 0.2 (CH3CN/H2O 2:1); max(KBr)/cm-1 3422, 1640, 1389, 1254, 1040 and 
835; H(300 MHz; D2O) 7.7 (s, 2 H, 5-H triazole), 7.2 (t, J 6.8, 1H, 5-H), 7.1 (s, 1 H, 2-H), 6.8 (d,  J 
6.8, 1H, 4-H), 6.6 (d, J 6.8, 1H, 6-H), 5.3-4.8 (m, 18H, 1'-H overlapped 4 H, triazole-CH2-O), 4.0-3.0 
(m, 80H), 3.0 (m, 2H), 2.9 (m, 2H); m/z (ESI-MS) calcd. for [M+Na2]
2+ = 1253,4, found 1253.7.  
2-(O-Di-(1-(6'-deoxy-βCD-6'-yl)-1H-1,2,3-triazol-4-yl)methyl)-βCD (17).  
The reaction was carried out in DMF with di-2I-O-propargyl-6I-VII-O-TBDMS-CD (2) (414 mg, 0.2 
mmol) and 61-azido-61-deoxy-CD (5) (525 mg, 0.45 mmol). Acetone (30 ml) was added to the 
reacted mixture, the precipitate was filtered off, washed with a cold 40 mM solution of 
diethylenetriamine-pentaacetic acid sodium salt (20 mL) to remove copper, and finally with water. The 
6I-VIITBDMS β-β trimer is a white powder (618 mg, 0.14 mmol, yield 68%). max(KBr)/cm-1 3422, 
1474, 1364, 1254, 1082, 1038 and 835; H(300 MHz; DMSO-d6) 8.0 (s, 2H, 5-H triazole), 5.1-4.6 (m, 
25H, 1-H overlapped 4 H, triazole-CH2-O), 3.8-3,2 (m, overlapped with H2O), 0.88 (s, 63H, t-but), 
0.04 (s, 42H, Si-CH3); m/z (MALDI-TOF MS) calcd. for [M+Na]
+ 4350.749, found 4350.952. Starting 
with 6I-VIITBDMS β-β trimer (618 mg, 0.143 mmol), we obtained trimer 17 (290 mg, 0.082 mmol, 
yield 58%) as a white powder. Rf = 0.06 (CH3CN/H2O 2:1); max(KBr)/cm-1 3422, 1465, 1380, 1270, 
1095, and 850; H(300 MHz; D2O) 8.0 (s, 1H, 5-H triazole), 5.2-4.9 (m, 25H, 1'-H overlapped 4 H 
triazole-CH2-O), 4.1 (br t, J 7.5, 2H), 3.9-3.2 (m, 120H), 3.1 (m, 2H), 2.8 (m, 2H); C(75 MHz; D2O) 
144.3 (C-4 triazole) 127.3 (C-5 triazole), 102.3-101.8 (C-1'), 81.7-81.5 (C-4'), 73.5-73.0 (C-5'), 72.4-
71.8 (C-2',C-3'), 69.8 (C triazole-CH2-O), 61.3-60.5 (C-6'); m/z (ESI-MS) m/z (MALDI-TOF MS) 
calcd. for [M+Na]+ 3552.144, found 3552.523. 
 
6A,6D-bis((4-(6'-βCD-2'-yl)-1H-1,2,3-triazol-1-yl)-6A,6D-dideoxy-βCD (18).  
The reaction was carried  out with 6A,6D-dideoxy-6A,6D-diazido-βCD (12) (80 mg, 0.067 mmol) and 
2I-O-propargyl-6I-VII-O-TBDMS-CD (2) (264 mg, 0.135 mmol). The solvent was then  partially 
evaporated and the reacted mixture was diluted with CHCl3, washed with H2O (3 x 20 ml), dried 
(Na2SO4) and evaporated to dryness. The crude product, purified by CC (CHCl3/CH3OH = , 9:1, 4:1), 
yielded the desired 6I-VIITBDMS β-β trimer (252 mg, 0.049 mmol, 73%) as a white powder. 
max(KBr)/cm-1 3422, 1475, 1389, 1263, 1090, 1038 and 835; H(300 MHz; DMSO-d6) 7.99 (1 H, s, 5-
H triazole), 6.0-5.5 (OH, m); 5.0-4.5 (25 H, m, 1-H overlapped 4 H, triazole-CH2-O), 4.20-3.15 (126 
H, m), 0.8 (s, 126 H, t-but), 0.01 (s, 84 H, Si-CH3); m/z (MALDI-TOF MS) calcd. for [M+Na]
+ 
5149.4, found 5149.4. Starting from 6I-VIITBDMS β-β trimer (150 mg, 0.029 mmol), the mixture, 
stirred overnight at room temperature, yielded tris-CD 18 (68 mg, 0.02 mmol, yield 68%) as a white 
powder. max(KBr)/cm-1 3412, 1477, 1390, 1255, 1085, 1038 and 835; H(300 MHz; D2O) 8.2 (s, 1H, 
5-H triazole), 5.3-4.4 (m, 25H, 1-H overlapped 4 H triazole-CH2-O), 4.0-3.5 (126 H, m), 2.8 (m, 
2H);C(75 MHz; D2O) 143.7, (C-4 triazole), 127.4 (C-5 triazole), , 102.2-101.7 (C-1'), 81.9-81.4 (C-
4'), 73.4 (C-5’) 72.3-71.8 (C-2',C-3'), 66.2 (C triazole-CH2-O), 60.6-59.3 (C6') m/z (MALDI-TOF MS) 
calcd. for [M+Na]+ 3552.144 found 3552.417. 
 
Water proton relaxivity measurements 
Longitudinal water-proton relaxation rates were measured by a Stelar Spinmaster spectrometer 
(Mede, PV- Italy) operating at 0.47 T, by means of the standard inversion-recovery technique (16 
experiments, 2 scans). Typical 90° pulse width was 7.5 s and the reproducibility of the T1 data 
was 0.5%. Temperature was controlled (0.1°C) with a Stelar VTC-91 air-flow heater equipped 
with a copper-constantan thermocouple. The proton 1/T1 NMRD profiles were measured over a 
continuum of magnetic field strength ranging from 0.00024 to 0.47 T (corresponding to 0.01-20 
MHz proton Larmor Frequency) on a Stelar field-cycling relaxometer. This works under complete 
computer control with an absolute uncertainty in 1/T1 of 1%. Data points from 0.47 T (20 MHz) 
to 1.7 T (70 MHz) were collected on a Stelar Spinmaster spectrometer  
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